Anteris Technologies Ltd. (AVR) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Anteris Technologies Ltd. (AVR:NASDAQ), powered by AI.

Current Price
$9.27
Market Cap
342M
Sector
Healthcare
What is the Anteris Technologies Ltd. stock price forecast?

Anteris Technologies Ltd. is currently trading at $9.27. View real-time AI analysis on Alpha Lenz.

What is Anteris Technologies Ltd. insider trading activity?

View the latest insider trading data for Anteris Technologies Ltd. on Alpha Lenz.

What is Anteris Technologies Ltd.'s P/E ratio?

View Anteris Technologies Ltd.'s valuation metrics on Alpha Lenz.

Anteris Technologies Ltd.

NASDAQ · AVR
$9.27-0.15(-1.59%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Anteris Technologies Ltd.'s future dividend policy...

Company Overview

Anteris Technologies Ltd. is a pioneering company in the medical technology sector, specializing in the development of innovative heart valve products. The primary focus of the company is to enhance heart valve therapy, offering bioprosthetic solutions designed to improve patient outcomes and durability of valve implants. Anteris Technologies operates at the forefront of cardiovascular health, with its key offerings targeting the significant needs in the treatment of aortic stenosis, a common and severe heart valve disease. Its technologically advanced products aim to deliver effective and long-lasting solutions for patients across the globe. The company plays a crucial role in the healthcare industry by pushing the boundaries of medical research and development. Its commitment to addressing unmet medical needs is reflected in its substantial investments in product innovation and clinical trials. Anteris Technologies collaborates with medical professionals and institutions to drive the adoption of its cutting-edge technologies. As part of the global medical device market, Anteris is poised to influence the future of cardiac care through its dedication to high-performance and patient-centered solutions.

CEOMr. Wayne Geoffrey Paterson
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees136

Company Statistics

FY 2025

Profile

$342.17MMarket Cap
N/ARevenue
0.00Shares Out
136Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

N/AROA
N/AROE
N/AROIC

Financial Health

N/ACash & Cash Equivalents
N/ANet Debt
N/ADebt/Equity
N/AInterest Cov

Frequently Asked Questions

Anteris Technologies Ltd. (ticker: AVR) is a company listed on NASDAQ in the Healthcare sector (Medical Instruments & Supplies). It has approximately 136 employees. Market cap is $342M.

The current price is $9.27 with a P/E ratio of -x and P/B of -x.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Anteris Technologies Ltd. (AVR) Stock Forecast 2026 $9.27 — Price, Financials & Analyst Targets | Alpha Lenz